相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Experience with ustekinumab for the treatment of moderate to severe Hidradenitis suppurativa
W. P. Gulliver et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2012)
A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa
I. Miller et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Elevated levels of tumour necrosis factor (TNF)-α, interleukin (IL)-1β and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-α and IL-1β
H. H. van der Zee et al.
BRITISH JOURNAL OF DERMATOLOGY (2011)
Hidradenitis suppurativa: a review of cause and treatment
Shiva Yazdanyar et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2011)
Deficiency of IL-22 Contributes to a Chronic Inflammatory Disease: Pathogenetic Mechanisms in Acne Inversa
Kerstin Wolk et al.
JOURNAL OF IMMUNOLOGY (2011)
Treatment of Hidradenitis Suppurativa With Etanercept Injection
David R. Adams et al.
ARCHIVES OF DERMATOLOGY (2010)
Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study
H. H. van der Zee et al.
BRITISH JOURNAL OF DERMATOLOGY (2010)
Infliximab therapy for patients with moderate to severe hidradenitis, suppurativa: A randomized, double-blind, placebo-controlled crossover trial
Annika Grant et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2010)
Increased Serum Tumour Necrosis Factor-alpha in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor-alpha Agents?
Lukasz Matusiak et al.
ACTA DERMATO-VENEREOLOGICA (2009)
A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa
Robert A. Lee et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Hidradenitis suppurativa: A comprehensive review
Ali Alikhan et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Targeting tumor necrosis factor α in psoriasis and psoriatic arthritis
Francesca Fantuzzi et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2008)
Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies
Jean E. Revuz et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Tumor necrosis factor antagonist mechanisms of action: A comprehensive review
Daniel Tracey et al.
PHARMACOLOGY & THERAPEUTICS (2008)
An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa
E. J. Giamarellos-Bourboulis et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Long-term efficacy of a single course of infliximab in hidradenitis suppurativa
J. R. Mekkes et al.
BRITISH JOURNAL OF DERMATOLOGY (2008)
Targeting TNFα rapidly reduces density of dendritic cells and macrophages in psoriatic plaques with restoration of epidermal keratinocyte differentiation
Deborah J. Marble et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2007)
A modified ex vivo skin organ culture system for functional studies
AR Companjen et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2001)
分享论文
